Biocon debt ratings affirmed, management to meet investors

Biocon Limited announced that India Ratings and Research, in a press release dated December 09, 2025, affirmed the credit ratings for several of the company's debt instruments. Bank loan facilities totaling INR 5,500 million were assigned an IND AA+/Stable/IND A1+ rating, while proposed commercial paper of INR 8,000 million received an IND A1+ rating. Additionally, bank loan facilities amounting to INR 4,500 million were affirmed at IND AA+/Stable/IND A1+. A non-convertible debenture of INR 10,700 million was withdrawn after being paid in full.

The company also reported a proposed commercial paper issuance of INR 12,000 million, which was affirmed with an IND A1+ rating.

In a separate announcement, Biocon confirmed that its management is scheduled to meet with analysts and institutional investors from December 15-19, 2025. These meetings will be conducted in person or virtually, in a 1x1/Group format, with Mumbai listed as the venue. The company emphasized that no unpublished price sensitive information will be disclosed during these sessions.